# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023, Regulation 20: Amendment of regulation 16 (clinical investigation fees)


In regulation 16(5)—
(a) in sub-paragraph (a), for “non-invasive class IIb device” substitute “class IIb device, which is neither an implantable device nor a long-term invasive device” and
(b) in sub-paragraph (b), for “an invasive class IIb device or class III device” substitute “a class IIb device, which is either an implantable device or a long-term invasive device or a class III device”.

---
Source: https://www.legislation.gov.uk/ukdsi/2023/9780348244502/regulation/20 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-20
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

